Development and validation of a novel diagnostic model for initially clinical diagnosed gastrointestinal stromal tumors using an extreme gradient-boosting machine
Open Access
- 18 December 2021
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 21 (1) , 1-9
Abstract
Introduction: Gastrointestinal stromal tumor (GIST) is the most common gastrointestinal soft tissue tumor. Clinical diagnosis mainly relies on enhanced CT, endoscopy and endoscopic ultrasound (EUS), but the misdiagnosis rate is still high without fine needle aspiration biopsy. We aim to develop a novel diagnostic model by analyzing the preoperative data of the patients. Methods: We used the data of patients who were initially diagnosed as gastric GIST and underwent partial gastrectomy. The patients were randomly divided into training dataset and test dataset at a ratio of 3 to 1. After pre-experimental screening, max depth = 2, eta = 0.1, gamma = 0.5, and nrounds = 200 were defined as the best parameters, and in this way we developed the initial extreme gradient-boosting (XGBoost) model. Based on the importance of the features in the initial model, we improved the model by excluding the hematological features. In this way we obtained the final XGBoost model and underwent validation using the test dataset. Results: In the initial XGBoost model, we found that the hematological indicators (including inflammation and nutritional indicators) examined before the surgery had little effect on the outcome, so we subsequently excluded the hematological indicators. Similarly, we also screened the features from enhanced CT and ultrasound gastroscopy, and finally determined the 6 most important predictors for GIST diagnosis, including the ratio of long and short diameter under CT, the CT value of the tumor, the enhancement of the tumor in arterial period and venous period, existence of liquid area and calcific area inside the tumor under EUS. Round or round-like tumors with a CT value of around 30 (25–37) and delayed enhancement, as well as liquid but not calcific area inside the tumor best indicate the diagnosis of GIST. Conclusions: We developed a model to further differential diagnose GIST from other tumors in initially clinical diagnosed gastric GIST patients by analyzing the results of clinical examinations that most patients should have completed before surgical resection.Keywords
All Related Versions
Funding Information
- Peking University People's Hospital (RDL2020-06)
This publication has 22 references indexed in Scilit:
- Gastrointestinal Stromal TumorsJournal of Clinical Oncology, 2018
- GEIS guidelines for gastrointestinal sarcomas (GIST)Cancer Treatment Reviews, 2017
- Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal TumorCancer Research and Treatment, 2016
- XGBoost2016
- Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studiesCancer Epidemiology, 2016
- Machine Learning in MedicineCirculation, 2015
- Impact of Periodic Endoscopy on Incidentally Diagnosed Gastric Gastrointestinal Stromal Tumors: Findings in Surgically Resected and Confirmed LesionsAnnals of Surgical Oncology, 2015
- MissForest—non-parametric missing value imputation for mixed-type dataBioinformatics, 2011
- Accuracy of EUS in the evaluation of small gastric subepithelial lesionsGastrointestinal Endoscopy, 2010
- A systematic review on the clinical diagnosis of gastrointestinal stromal tumorsJournal of Surgical Oncology, 2008